602 related articles for article (PubMed ID: 11309628)
21. Apoptosis of HIV-specific CD8+ T cells: an HIV evasion strategy.
Petrovas C; Mueller YM; Katsikis PD
Cell Death Differ; 2005 Aug; 12 Suppl 1():859-70. PubMed ID: 15818412
[No Abstract] [Full Text] [Related]
22. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
Mascarell L; Fayolle C; Bauche C; Ladant D; Leclerc C
J Virol; 2005 Aug; 79(15):9872-84. PubMed ID: 16014948
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxic CD4 T cells in viral hepatitis.
Aslan N; Yurdaydin C; Wiegand J; Greten T; Ciner A; Meyer MF; Heiken H; Kuhlmann B; Kaiser T; Bozkaya H; Tillmann HL; Bozdayi AM; Manns MP; Wedemeyer H
J Viral Hepat; 2006 Aug; 13(8):505-14. PubMed ID: 16901280
[TBL] [Abstract][Full Text] [Related]
24. The dynamics of the cellular immune response to HIV infection: implications for vaccination.
McMichael AJ; Callan M; Appay V; Hanke T; Ogg G; Rowland-Jones S
Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1007-11. PubMed ID: 11186301
[TBL] [Abstract][Full Text] [Related]
25. High levels of human immunodeficiency virus infection of CD8 lymphocytes expressing CD4 in vivo.
Cochrane A; Imlach S; Leen C; Scott G; Kennedy D; Simmonds P
J Virol; 2004 Sep; 78(18):9862-71. PubMed ID: 15331721
[TBL] [Abstract][Full Text] [Related]
26. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
[TBL] [Abstract][Full Text] [Related]
27. Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.
Weinberg A; Wohl DA; Barrett RJ; van der Horst C
J Infect Dis; 2001 Sep; 184(6):707-12. PubMed ID: 11517431
[TBL] [Abstract][Full Text] [Related]
28. Understanding the mechanisms and limitations of immune control of HIV.
Davenport MP; Ribeiro RM; Zhang L; Wilson DP; Perelson AS
Immunol Rev; 2007 Apr; 216():164-75. PubMed ID: 17367342
[TBL] [Abstract][Full Text] [Related]
29. Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of beta-chemokines in contrast to infected humans.
Ondoa P; Vereecken C; Fransen K; Colebunders R; van der Groen G; Heeney JL; Kestens L
J Med Virol; 2003 Mar; 69(3):297-305. PubMed ID: 12526038
[TBL] [Abstract][Full Text] [Related]
30. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy.
Valor L; Navarro J; Carbone J; Rodríguez-Sáinz C; Gil J; López F; Fernández-Cruz E;
Vaccine; 2008 May; 26(22):2738-45. PubMed ID: 18433946
[TBL] [Abstract][Full Text] [Related]
31. Immunoregulation, immune defects, and clinical strategies in HIV infection.
Lane HC
Mt Sinai J Med; 1992 May; 59(3):244-52. PubMed ID: 1534869
[TBL] [Abstract][Full Text] [Related]
32. CD4(+) T helper cells and the role they play in viral control.
Norris PJ; Rosenberg ES
J Mol Med (Berl); 2002 Jul; 80(7):397-405. PubMed ID: 12110945
[TBL] [Abstract][Full Text] [Related]
33. [Current advances in HIV pathogenesis. Results of therapy and vaccine development].
Wagner R; Mayer J; Wolf H
Dtsch Med Wochenschr; 1995 May; 120(20):728-36. PubMed ID: 7758413
[No Abstract] [Full Text] [Related]
34. T-cell strategies in AIDS vaccines: MHC-restricted T-cell responses to HIV proteins.
Mills KH; Nixon DF; McMichael AJ
AIDS; 1989; 3 Suppl 1():S101-10. PubMed ID: 2575396
[No Abstract] [Full Text] [Related]
35. [Immunologic changes associated with human immunodeficiency virus (HIV)].
Brígido LF; Duarte AJ
AMB Rev Assoc Med Bras; 1989; 35(3):111-6. PubMed ID: 2534492
[TBL] [Abstract][Full Text] [Related]
36. AIDS: immunologic abnormalities following human immunodeficiency virus infection.
Batra P
J Thorac Imaging; 1991 Sep; 6(4):1-5. PubMed ID: 1942190
[TBL] [Abstract][Full Text] [Related]
37. Polyspecific self-reactive antibodies in individuals infected with human immunodeficiency virus facilitate T cell deletion and inhibit costimulatory accessory cell function.
Wang Zq; Horowitz HW; Orlikowsky T; Hahn BI; Trejo V; Bapat AS; Mittler RS; Rayanade RJ; Yang SY; Hoffmann MK
J Infect Dis; 1999 Oct; 180(4):1072-9. PubMed ID: 10479133
[TBL] [Abstract][Full Text] [Related]
38. HIV evolution and progression of the infection to AIDS.
Huang G; Takeuchi Y; Korobeinikov A
J Theor Biol; 2012 Aug; 307():149-59. PubMed ID: 22634206
[TBL] [Abstract][Full Text] [Related]
39. Impact of immune plasticity on development of cellular memory responses to human immunodeficiency virus type 1.
Kolber MA
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1002-7. PubMed ID: 15539497
[No Abstract] [Full Text] [Related]
40. Two types of cytotoxic lymphocyte regulation explain kinetics of immune response to human immunodeficiency virus.
Rouzine IM; Sergeev RA; Glushtsov AI
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):666-71. PubMed ID: 16407101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
